Latest News about FLHLF
Recent news which mentions FLHLF
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
April 17, 2024
From Benzinga
From Benzinga
Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
March 01, 2024
From Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
February 15, 2024
From Benzinga
'Rainforests Are Nature's Medicine Cabinets': Biotech Co. Performs Fresh Research On Traditional Plants For Modern Mental Health Challenges
January 30, 2024
From Benzinga
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
January 26, 2024
From Benzinga
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
December 27, 2023
From Benzinga
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
September 26, 2023
From Benzinga
Peru's Coca Leaf Will Be Used For Research Toward Treating ADHD, Learn The Details
September 21, 2023
From Benzinga
Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials
August 23, 2023
Tickers
FLHLF
From Benzinga
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
August 21, 2023
From Benzinga
Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing
August 15, 2023
From Benzinga
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
July 24, 2023
From Benzinga
Filament Health Uplisting To NASDAQ In A $210M SPAC Deal
July 19, 2023
From Benzinga
Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More
July 11, 2023
From Benzinga
Filament Supplies Botanical Psilocybin To Canadian Researchers, Inks Global Licensing Deal
July 07, 2023
Tickers
FLHLF
From Benzinga
UCSF Clinical Trial Shows Promising Results For Naturally-Sourced Psilocybin And Psilocin
May 30, 2023
Tickers
FLHLF
From Benzinga
From Benzinga
African Iboga Root Heads To Canadian Company Developing Natural Drugs To Help Treat Addictions
May 17, 2023
Tickers
FLHLF
From Benzinga
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
May 15, 2023
From Benzinga
From Benzinga
Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
April 17, 2023
From Benzinga
Two Psychedelics Companies Collaborate To Provide Clinical-Grade MDMA Capsules For Authorized Patients And Studies
April 11, 2023
Tickers
FLHLF
From Benzinga
Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill
April 03, 2023
From Benzinga
Psychedelic Research Expands In Australia With Palliative Care Partnership & New MDMA Analog Portfolio
March 21, 2023
From Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
March 20, 2023
From Benzinga
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
March 15, 2023
From Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
February 27, 2023
From Benzinga
[Video] Revolutionizing Mental Health: Filament Health CEO Discusses The Future Of Psychedelic Medicine
February 21, 2023
Tickers
FLHLF
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.